Search Orphan Drug Designations and Approvals
-
Generic Name: | angiotensin (1-7) |
---|---|
Date Designated: | 08/30/2013 |
Orphan Designation: | Treatment of patients requiring stem cell transplantation to accelerate the mobilization of hematopoietic stem cells (CD34+) from the bone marrow to the peripheral blood when combined with a granulocyte colony-stimulating factor |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
US Biotest, Inc. 231 Bonetti Drive San Luis Obispo, California 93401 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-